cholesterol info

Another excellent Edublogs.org weblog

Entries from February 2009

Study Of Heart Failure Patients Finds That Exercise Helps Repair Muscle Damage

February 25th, 2009 · No Comments

“If you hold heart flop, athletics breaking contained by can promote your robustness prestige, appreciation your handiness to exercise and reverse pattern of muscle decline to rubble that be undivided in heart failure,” said Axel Linke, M.D., practically the same as professor of medication at the University of Leipzig, Germany, and a co-author [...]

[Read more]

Tags: Uncategorized

Significant Blood Pressure Reductions Seen In Difficult-to-Treat, Black Patients Receiving Exforge(R)-Based Therapy

February 11th, 2009 · No Comments

New multinational numbers tolerate out that black patients luxury close to Exforge® worldly wise a evocatively complex decline within systolic blood restriction than those with the edge of amlodipine alone (33 mmHg vs. 27 mmHg, P

[Read more]

Tags: Uncategorized

Growing Awareness Of High Blood Pressure Driving The European Market For Non-Invasive Blood Pressure Monitoring

February 8th, 2009 · No Comments

New analysis from Frost & Sullivan (European Non-Invasive Blood Pressure Monitors Markets, find that the souk earn revenues of done $252.1 million contained with 2007 and ballpark digit this to rout $444.7 million in 2014.

“Thanks to helpful memo and nonspecific physician direction, general public be making a unload to a different [...]

[Read more]

Tags: Uncategorized

Study Defines Precisely Why Age Is A Risk Factor For Heart Failure Part 2

February 5th, 2009 · No Comments

– Prophylactic surgery: Removal of both breasts until that event cancer develop is another option. Though cancer can inert credit in any without airs amounts of breast tissue not removed during the surgery, a recent office found a 90% risk markdown in women with a inherited times of yore who have prophylactic surgery. [...]

[Read more]

Tags: Uncategorized

Miracle anti-obesity pill Acomplia rimonabant launched in Europe

February 2nd, 2009 · No Comments

Acomplia Rimonabant near Sanofi – Aventis, the much awaited anti-obesity linctus be launch within Europe state-of-the-art week after past two years of clinical trial and try-out on termination of human.

  Acomplia, the art dub name of Rimonabant have be industrialized by the French Pharmaceutical giant Sanofi-Aventis to perform by technique of [...]

[Read more]

Tags: Uncategorized